ImmPACT Bio to Present New Preclinical Data for CD19/CD20 Bispecific CAR-T Cell Therapy in Multiple Sclerosis
/PRNewswire/ -- ImmPACT Bio USA Inc. (ImmPACT Bio), a clinical-stage biopharmaceutical company developing a new generation of cellular therapies that have the...
United States Ethan Bendavid Sumant Ramachandra Music City Center Immpact Bio United States Inc Consortium Of Multiple Sclerosis Centers
Source: prnewswire.com